Pharvaris (PHVS) Accumulated Expenses (2019 - 2026)

Pharvaris' Accumulated Expenses history runs 8 years deep, the most recent figure standing at $22.3 million for Q1 2026.

• Quarterly Accumulated Expenses rose 23.5% year-over-year to $22.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.3 million (up 23.5% YoY) and the FY2025 annual result came in at $26.4 million, up 38.57% from the prior year.
• Accumulated Expenses was $22.3 million for Q1 2026 at Pharvaris, down from $27.2 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $27.2 million in Q4 2025 and bottomed at $7.3 million in Q1 2022.
• A 5-year average of $15.5 million and a median of $13.2 million in 2024 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2022 — Accumulated Expenses surged 137.53% — and 2024, when it climbed 6.07%.
• Pharvaris' Accumulated Expenses stood at $11.1 million in 2022, then climbed by 7.17% to $11.9 million in 2023, then surged by 57.83% to $18.8 million in 2024, then surged by 44.61% to $27.2 million in 2025, then retreated by 17.96% to $22.3 million in 2026.
• Business Quant data shows PHVS's Accumulated Expenses at $22.3 million in Q1 2026, $27.2 million in Q4 2025, and $26.5 million in Q3 2025.